Mirtazapine in Alzheimer-associated Weight Loss
NCT01505504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2012-01-06
Summary
Weight loss is a frequent problem associated with Alzheimers disease (AD). Mirtazapine has weight loss as a frequent side effect.
The aim of this retrospective study is to check whether mirtazapine 30 mg (once daily) can counteract weight loss in patients with AD or mixed dementia (AD + vascular).
Conditions
- Alzheimer's Disease
- Weight Loss
- Mixed Dementia
- Dementia
Interventions
- DRUG
-
mirtazapine
30 mg at bedtime
Sponsors & Collaborators
-
Brugmann University Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Primary Completion
- 2011-11-30
- Completion
- 2011-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease
NCT03250741 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT05552157 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
NCT02190084 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
NCT03507790 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
NCT01461174 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
NCT01009255 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients
NCT00503516 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
NCT01492374 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
NCT00862940 ·Status: COMPLETED ·Phase: PHASE4
-
An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum
NCT02406027 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease
NCT02260674 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo
NCT01827982 ·Status: COMPLETED ·Phase: PHASE1
-
Applying PET/MR for Dementia Applications
NCT04154254 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Apathy in Alzheimer's Disease With Modafinil
NCT01172145 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease
NCT06850597 ·Status: RECRUITING ·Phase: PHASE2
-
Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment
NCT02007291 ·Status: COMPLETED
-
A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease
NCT01478204 ·Status: COMPLETED
-
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
NCT02931136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease
NCT01921972 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
NCT00322153 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants
NCT02792179 ·Status: COMPLETED ·Phase: PHASE1